(Press-News.org) Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for therapeutics. Among them, the Y220C mutation is the ninth most frequent and it creates a small crevice in the mutant protein that is not present in the wild type conformation. This druggable cavity has led to the development of small molecules such as rezatapopt that are designed to restore p53 and reactivate its normal tumor suppressor function. Rezatapopt has shown promising efficacy in early studies, but as with most targeted therapies, patients can eventually develop resistance to treatment.
A new study by Mass General Brigham investigators identifies mutations that drive clinical resistance to rezatapopt treatment. Researchers analyzed samples from patients who developed resistance to this drug and validated the underlying mechanisms using preclinical experiments, suggesting a path forward toward overcoming resistance. Results are published in Cancer Discovery.
“Our findings establish a molecular basis for why patients treated with rezatapopt may experience therapeutic failure and provide the first clinical evidence that on-target secondary TP53 mutations can lead to acquired resistance. This work galvanizes us to further investigate whether next-generation agents or combination therapies may overcome or delay the emergence of resistance,” said first author Ferran Fece de la Cruz, PhD, an instructor with the Krantz Family Center for Cancer Research at the Mass General Brigham Cancer Institute.
Seeking insight, the investigators examined blood and tumor samples from two patients enrolled in the ongoing PYNNACLE clinical trial, which is evaluating rezatapopt in participants with metastatic solid tumors with a Y220C mutation. The patients, each of whom had different types of solid tumors, both responded to treatment initially but eventually became resistant to the drug. Genetic analyses of tumor DNA revealed several new TP53 mutations that emerged during treatment — including nearly 100 new mutations in one of the patient’s samples.
To characterize how these new mutations led to drug insensitivity, the research team expressed them along with Y220C in cultured cancer cells. The researchers found that the acquired mutations fell into two main categories: those that altered p53 transcriptional activity and thus impaired its function, and others that potentially altered the Y220C pocket and disrupted rezatapopt binding.
The authors note that the former class of mutation is more likely to cause universal drug resistance to all agents within this therapeutic class, while the latter may be more drug-specific and circumvented with improved strategies, such as next-generation Y220C reactivators with a distinct mode of action. Further studies involving larger cohorts are needed to evaluate different types of acquired drug resistance.
Authorship: In addition to Ferran Fece de la Cruz, Mass General Brigham authors include Andreas Varkaris, Parasvi S Patel, Elijah W Kushner, Alvin A Morales-Giron, Sangmi Sandra Lee, Ankit Singh, Clara T Kim, Bryanna L Norden, Sara Ehnstrom, Jakob M Riedl, Jacquelyn M Curtis, Haley Barnes, Allison M Kehlmann, Nicholas Chevalier, Hitomi S Okuma, Manisha Patel, Lori Wirth, Leontios Pappas, Kayao Lau, Dejan Juric, Jessica L Hopkins, Doga C Gulhan, Aparna R Parikh and Ryan B Corcoran. Additional authors include Brendan Connell, Francis Nugent, Keelan Z Guiley, and Kevan M Shokat.
Paper cited: Fece de la Cruz, Ferran et al. “Acquired on-target alterations drive clinical resistance to p53-Y220C reactivators” Cancer Discovery DOI: 10.1158/2159-8290.CD-25-1761
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
Under tennis’s rules, the winner of a match is the player who wins the greater number of sets. In the majority of cases, that is also the player who wins the most games, too—but not always.
Ahead of this year’s Australian Open, a team of game theorists has highlighted a rare but striking fairness problem: a player can win a match on sets while winning fewer games overall than their opponent.
In their research, which appears in the Journal of Sports Analytics, New York University’s Steven Brams, Wilfrid Laurier University’s Marc Kilgour, and King’s College London’s Mehmet Mars Seven analyzed more ...
Diagnoses of depression, one of the most common mental disorders, increased by nearly 50% between 1990 and 2017, according to data from the World Health Organization (WHO). Currently, depression affects around 5% of the world's population. In Catalonia, the number of people diagnosed with the condition has also risen significantly in recent years. Between 2017 and 2022, the figures for depression and mood disorders grew by 86.6%, as reported by Catalonia's public network of primary healthcare centres.
New technologies to ...
Although honey bees have the ability to regulate hive temperatures, new research published in Ecological and Evolutionary Physiology shows that extreme summer heat can overwhelm these critical pollinators' cooling systems, leading to significant colony population declines.
The research in “Negative Effects of Excessive Heat on Colony Thermoregulation and Population Dynamics in Honey Bees,” conducted during a hot Arizona summer, monitored nine honey bee colonies through three months of temperatures that frequently exceeded 40°C (104°F). The results indicate that intensifying heat waves worldwide represent a significant threat to honey bees ...
January 12, 2026 – New research has identified that neuroinflammation driven by microglia (immune cells in the brain) is a primary underlying driver of prolonged negative feelings caused by repeated, sustained binge drinking (binge exposure). Negative emotional states caused by alcohol contribute to alcohol use disorder (AUD) and its associated mental health conditions such as depression. The findings from a study in The American Journal of Pathology, published by Elsevier, open the door for immune therapies to treat AUD, for which effective treatments are currently limited.
The natural history of AUD ...
About The Study: This qualitative analysis characterizes the Food and Drug Administration’s (FDA’s) decision-making with respect to the regulation of mifepristone, with a particular interest in the agency’s rationale for establishing, maintaining, or modifying key components of its regulatory approach over time.
Corresponding Author: To contact the corresponding author, G. Caleb Alexander, MD, MS, email galexan9@jhmi.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.23091)
Editor’s ...
About The Study: Despite decades of guidelines cautioning against their use, many older adults receive potentially inappropriate central nervous system-active medications. Patients with cognitive impairment were more likely than those with normal cognition to receive such medications.
Corresponding Author: To contact the corresponding author, John N. Mafi, MD, MPH, email jmafi@mednet.ucla.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.23697)
Editor’s Note: Please see the article for additional information, including other authors, ...
Despite years of clinical guidelines warning against the practice, one in four Medicare beneficiaries with dementia is prescribed brain-altering medications linked to falls, confusion, and hospitalization, according to new research to be published January 12 in the peer-reviewed journal JAMA.
While prescriptions for these medications fell from 20% to 16% over the nine-year study period among all Medicare beneficiaries, they continue to be prescribed to individuals with cognitive impairment who are particularly susceptible ...
About The Study: In this cohort study of students in grades 4 through 12, social media’s association with adolescent well-being was complex and nonlinear, varying by age and sex. While heavy use was associated with poorer well-being and abstinence sometimes coincided with less favorable outcomes, these findings are observational and should be interpreted cautiously.
Corresponding Author: To contact the corresponding author, Ben Singh, PhD, email ben.singh@unisa.edu.au.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2025.5619)
Editor’s ...
About The Study: This study found that overall, from 2022 to 2025, most counties experienced a population-level decline in child poverty rates, with rates for Black and Hispanic children experiencing the greatest changes. Despite overall decline, Black and Hispanic children continued to experience disproportionately higher poverty rates compared with white children.
Corresponding Author: To contact the corresponding author, Daniyal Zuberi, MSc, AM, PhD, email daniyal.zuberi@utoronto.ca.
To access the ...
As we age, we don’t recover from injury or illness like we did when we were young. But new research from UCSF has found gene regulators — proteins that turn genes on and off — that could restore the aging body’s ability to self-repair.
The scientists looked at fibroblasts, which build the scaffolding between cells that give shape and structure to our organs.
Fibroblasts maintain this scaffolding in the face of normal wear, disease, and injury. But over time, they slow down, and the body suffers.
The study found telltale signs of decline in the way that old fibroblasts expressed their ...
